Similarly, the longitudinal change in biological monitoring (eg, serum calcium-phosphate product) and patients’ CKD stage could not be evaluated or confirmed in the historical control cohort because laboratory data (eg, albumin creatinine ratio, red and white blood cell counts) were not available. The gene discussed is ALB; the disease is chronic kidney disease.